Medical marijuana is nothing new, in fact it is legal in many places already. What is new is that the active ingredient in marijuana that gets people high has been shown to attack cancer cells that modern science cannot eliminate!
Investigators at Complutense University in Spain assessed the anti-tumor activity of the cannabinoids THC and CBD (cannabidiol) in glioma xenografts (tissue grafts).
Authors reported that the administration of THC in combination with TMZ (the benchmark agent for the management of glioblastoma) “enhanced autophagy” (programmed cell death) in malignant tissue. The combined administration of THC, CBD, and TMZ “remarkably reduce[d] the growth of glioma xenografts … [and] produced a strong antitumoral action in both TMZ-sensitive and TMZ-resistant tumors.”
They concluded, “Altogether, our findings support that the combined administration of TMZ and cannabinoids could be therapeutically exploited for the management of GBM (gliobastoma multiforme).”
A 2006 pilot study published in the British Journal of Cancer reported that the intratumoral administration of THC was associated with reduced tumor cell proliferation in two of nine human subjects with GBM, which is highly resistant to conventional anti-cancer treatments.